Home
Company
Management
Board of Directors
Advisory Board
Technology
Partnering
Product Pipeline
News
Cloud Pharmaceuticals forms Drug Design Collaboration with GSK
Cloud Pharmaceuticals CEO to Speak at Artificial Intelligence in Drug Development Congress 27-28 September 2017, London, UK
Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation
Cloud Pharmaceuticals CEO to Speak at the AI in Pharma Summit October17, 2017 in Boston.
Cloud Pharmaceuticals CEO and CSO to Speak at AI Pharma Innovation
Undruggable? Not to Cloud Pharmaceuticals
Cloud Pharmaceuticals Announces Crowdfunding Campaign to Aid in Drug Discovery for ALS and Zika Virus Research
Cloud Pharmaceuticals Announces Design of Active Pro-Drug for Treatment of Crohn's Disease and Ulcerative Colitis
Cloud Pharmaceuticals COO to Discuss Digital Tools for Drug Discovery and Development at the 2016 BIO International Convention
Cloud Pharmaceuticals Announces Completion of Computational Drug Discovery Projects and Resulting Development Programs
Cloud Pharmaceuticals Announces Participation at Upcoming Biotech, Life Sciences and Partnering Events
News: 2015
>
Cloud Pharmaceuticals to Present Cloud-Based Drug Design and Development at the Life Sciences Summit
Cloud Pharmaceuticals CEO to Discuss Positive Impacts of Digital Disruption on Drug Design
Cloud Pharmaceuticals Appoints Neurological Disorder Expert Jeff Vaught to Its Advisory Board
Cloud Pharmaceuticals and THERAMetrics Team Up to Target Orphan CNS Diseases
Cloud Pharmaceuticals Announces Fall 2015 Partnering and Presentation Schedule
Cloud Pharmaceuticals Strengthens Management Team with Appointment of Two C-Level Executives
Cloud Pharmaceuticals and Genomeon Announce Marker Discovery and Drug Design Partnership
Cloud Pharmaceuticals Welcomes Noted Life Sciences Experts to Its Advisory Board
Cloud Pharmaceuticals CEO Ed Addison to Present at BioTrinity 2015
Cloud Pharmaceuticals CEO to Discuss Improving the Accuracy of Drug Discovery at the 2015 Bio-IT World Conference & Expo
Cloud Pharmaceuticals and the University of Florida Department of Medicine Collaborate on the Rapid Design of Novel Cancer Inhibitors
Reducing the Cost and Increasing the Precision of Future Medicines
Cloud Pharmaceuticals Announces 2015 Partnering Sessions and Presentation Schedule
News: 2014
>
Cloud Pharmaceuticals Announces Partnering and Presentation Schedule
Cloud Pharmaceuticals Receives NSF SBIR Grant
Cloud Pharmaceuticals Enters R&D Agreement with MYOS Corporation
>
BioWorld: “Myos, Cloud collaborate"
Cloud Pharmaceuticals Granted 1M Hours of Supercomputer Time
TeraDiscoveries Changes Name to Cloud Pharmaceuticals
Cloud Pharmaceuticals to Assist Egenix in Cancer and Autism Research
Contact
Connect with us:
Product Pipeline
